BANK OF AMERICA CORP /DE/ - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$7,153,779
-19.5%
4,769,186
-14.7%
0.00%0.0%
Q2 2023$8,890,947
+121.8%
5,591,7900.0%0.00%
Q1 2023$4,009,314
+23.8%
5,591,790
-0.0%
0.00%
Q4 2022$3,237,708
+32277.1%
5,591,896
+55529.7%
0.00%
Q3 2022$10,000
+100.0%
10,052
+151.3%
0.00%
Q2 2022$5,000
-87.5%
4,000
-87.1%
0.00%
Q1 2022$40,000
-93.5%
30,889
-91.2%
0.00%
Q4 2021$619,000
+32.5%
351,662
+63.6%
0.00%
Q3 2021$467,000
-57.4%
214,930
-31.3%
0.00%
Q2 2021$1,096,000
-40.6%
312,951
+67.2%
0.00%
Q1 2021$1,846,000
-23.9%
187,183
-16.4%
0.00%
Q4 2020$2,427,000
-39.1%
223,924
-42.1%
0.00%
-100.0%
Q3 2020$3,983,000
-51.9%
386,703
-2.5%
0.00%0.0%
Q2 2020$8,286,000
+2163.9%
396,818
+961.1%
0.00%
Q1 2020$366,000
-68.1%
37,398
-62.5%
0.00%
Q4 2019$1,148,000
+73.2%
99,654
-18.0%
0.00%
Q3 2019$663,000
+51.4%
121,576
+230.2%
0.00%
Q2 2019$438,000
+500.0%
36,816
+163.2%
0.00%
Q1 2019$73,000
-43.0%
13,990
-65.5%
0.00%
Q4 2018$128,000
+50.6%
40,501
+185.8%
0.00%
Q3 2018$85,000
+66.7%
14,171
+48.8%
0.00%
Q2 2018$51,000
-54.1%
9,522
-50.0%
0.00%
Q1 2018$111,000
+484.2%
19,053
+152.4%
0.00%
Q2 2017$19,000
+72.7%
7,548
+85.3%
0.00%
Q1 2017$11,000
-31.2%
4,074
-27.4%
0.00%
Q4 2016$16,000
+433.3%
5,614
+604.4%
0.00%
Q3 2016$3,000
-75.0%
797
-78.8%
0.00%
Q2 2016$12,0003,7570.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders